Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ENDOXAN (cyclophosphamide)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ENDOXAN (cyclophosphamide)

Medicine - Posted on Apr 29 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • cyclophosphamide
history (2)
  • 4/13/16

    ENDOXAN (cyclophosphamide)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 2/15/06

    ENDOXAN 50 mg, comprimé enrobé Boite de 50 comprimés, code CIP 303 589-0 (cyclophosphamide)

    ENDOXAN 50 mg, comprimé enrobé Boite de 50 comprimés, code CIP 303 589-0 (cyclophosphamide)
    icône flèche
Technical information
ATC code
  • L01AA01
Manufacturer
BAXTER SAS
Presentation

ENDOXAN 50 mg, comprimé enrobé (code CIS : 62554177) plaquette(s) de 50 comprimé(s) - Code CIP : 3400930358900

All our publications
    Cancers - miscellaneous Drug therapy Urologic cancers

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
yg9MZfBD5211WVzq